| Nanoparticles for radiation therapy enhancement: the key parameters P Retif, S Pinel, M Toussaint, C Frochot, R Chouikrat, T Bastogne, ... Theranostics 5 (9), 1030, 2015 | 363 | 2015 |
| Improvement of meta-tetra(Hydroxyphenyl)chlorin-Like Photosensitizer Selectivity with Folate-Based Targeted Delivery. Synthesis and in Vivo Delivery Studies J Gravier, R Schneider, C Frochot, T Bastogne, F Schmitt, J Didelon, ... Journal of medicinal chemistry 51 (13), 3867-3877, 2008 | 168 | 2008 |
| Quality-by-design of nanopharmaceuticals–a state of the art T Bastogne Nanomedicine: Nanotechnology, Biology and Medicine 13 (7), 2151-2157, 2017 | 108 | 2017 |
| Multifunctional peptide-conjugated hybrid silica nanoparticles for photodynamic therapy and MRI H Benachour, A Sève, T Bastogne, C Frochot, R Vanderesse, ... Theranostics 2 (9), 889, 2012 | 97 | 2012 |
| A PMF-based subspace method for continuous-time model identification. Application to a multivariable winding process T Bastogne, H Garnier, P Sibille International Journal of Control 74 (2), 118-132, 2001 | 78 | 2001 |
| Quantum dot-folic acid conjugates as potential photosensitizers in photodynamic therapy of cancer V Morosini, T Bastogne, C Frochot, R Schneider, A François, F Guillemin, ... Photochemical & Photobiological Sciences 10, 842-851, 2011 | 71 | 2011 |
| Multivariable identification of a winding process by subspace methods for tension control T Bastogne, H Noura, P Sibille, A Richard Control engineering practice 6 (9), 1077-1088, 1998 | 63 | 1998 |
| Systems biology approach for in vivo photodynamic therapy optimization of ruthenium-porphyrin compounds M Pernot, T Bastogne, NPE Barry, B Therrien, G Koellensperger, S Hann, ... Journal of Photochemistry and Photobiology B: Biology 117, 80-89, 2012 | 62 | 2012 |
| mRNA-LNP vaccines tuned for systemic immunization induce strong antitumor immunity by engaging splenic immune cells S Bevers, SAA Kooijmans, E Van de Velde, MJW Evers, S Seghers, ... Molecular Therapy 30 (9), 3078-3094, 2022 | 60 | 2022 |
| Neuropilin-1 Targeting Photosensitization-Induced Early Stages of Thrombosis via Tissue Factor Release D Bechet, L Tirand, B Faivre, F Plénat, C Bonnet, T Bastogne, C Frochot, ... Pharmaceutical research 27, 468-479, 2010 | 51 | 2010 |
| The phosphorylated ATM immunofluorescence assay: a high-performance radiosensitivity assay to predict postradiation therapy overreactions G Vogin, T Bastogne, L Bodgi, J Gillet-Daubin, A Canet, S Pereira, ... International Journal of Radiation Oncology* Biology* Physics 101 (3), 690-693, 2018 | 43 | 2018 |
| The contsid toolbox: A software support for data-based continuous-time modelling H Garnier, M Gilson, T Bastogne, M Mensler Identification of continuous-time models from sampled data, 249-290, 2008 | 42 | 2008 |
| Application of subspace methods to the identification of a winding process T Bastogne, H Noura, A Richard, JM Hittinger 1997 European control conference (ECC), 2168-2173, 1997 | 42 | 1997 |
| Bridging communities in the field of nanomedicine B Halamoda-Kenzaoui, S Baconnier, T Bastogne, D Bazile, P Boisseau, ... Regulatory Toxicology and Pharmacology 106, 187-196, 2019 | 41 | 2019 |
| Response surface methodology: an extensive potential to optimize in vivo photodynamic therapy conditions L Tirand, T Bastogne, D Bechet, M Linder, N Thomas, C Frochot, ... International Journal of Radiation Oncology* Biology* Physics 75 (1), 244-252, 2009 | 41 | 2009 |
| Proton MR spectroscopy and diffusion MR imaging monitoring to predict tumor response to interstitial photodynamic therapy for glioblastoma M Toussaint, S Pinel, F Auger, N Durieux, M Thomassin, E Thomas, ... Theranostics 7 (2), 436, 2017 | 40 | 2017 |
| Phenomenological modeling of tumor diameter growth based on a mixed effects model T Bastogne, A Samson, P Vallois, S Wantz-Mézières, S Pinel, D Bechet, ... Journal of theoretical biology 262 (3), 544-552, 2010 | 33 | 2010 |
| Multinomial model-based formulations of TCP and NTCP for radiotherapy treatment planning R Keinj, T Bastogne, P Vallois Journal of theoretical biology 279 (1), 55-62, 2011 | 31 | 2011 |
| Real-time monitoring of photocytotoxicity in nanoparticles-based photodynamic therapy: a model-based approach H Benachour, T Bastogne, M Toussaint, Y Chemli, A Sève, C Frochot, ... PLoS One 7 (11), e48617, 2012 | 27 | 2012 |
| Validation of a phosphoprotein array assay for characterization of human tyrosine kinase receptor downstream signaling in breast cancer F Chergui, AS Chretien, S Bouali, C Ramacci, M Rouyer, T Bastogne, ... Clinical chemistry 55 (7), 1327-1336, 2009 | 27 | 2009 |
MURIEL BARBERI-HEYOBCRAN université de lorraine cnrsVerified email at univ-lorraine.fr
